Panacea Biotec's share price saw a 5 percent increase in early trade on December 15. This surge followed the company's launch of a fully-liquid wP-IPV-based pentavalent vaccine named 'EasyFourPol' in India
At 09:23 am, Panacea Biotec was quoting at Rs 171.70, up Rs 8.70, or 5.34 percent on the BSE.
"........ announced the launch of world’s first fully-liquid wP-IPV based Pentavalent vaccine, EasyFourPol, in India and registration of Valganciclovir 50 mg/ml Powder for Oral Solution by its step down wholly-owned subsidiary," the company said in a press release.
EasyFourPol is the world’s first fully liquid wP-IPV Pentavalent vaccine, which protects children against five deadly diseases i.e. Diphtheria, Tetanus, Pertussis, Polio, and invasive infections caused by Haemophilus Influenza Type b.
The company’s subsidiary Panacea Biotec Germany GmbH, in Germany, received registration of Valganciclovir Powder, which is a deoxynucleoside analogue cytomegalovirus DNA polymerase inhibitor indicated for i) the initial and maintenance treatment of cytomegalovirus (CMV) retinitis in adult patients with acquired immunodeficiency syndrome (AIDS) and ii) the prophylaxis of CMV disease in CMV-negative adults and children (from birth and up to 18 years of age) who have received an organ transplant from a CMV-positive donor.
Catch all market action in our live blog
In October, the company's material wholly-owned subsidiary Panacea Biotec Pharma Limited through its strategic partner Apotex Inc., Canada launched Paclitaxel protein-bound particles for injectable suspension (Albumin-Bound), a generic version of Abraxane in the Canadian market.
On October 12, US Food and Drug Administration slapped a Form 483 with nine observations on its biologics manufacturing plant in Baddi.
Panacea Biotec is biotechnology company doing research and development, manufacturing, sales, distribution and marketing of pharmaceutical products and vaccines.
In the quarter ended September 2023 the company turned profitable as it recorded a net profit of Rs 3.20 crore.
Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
